Thursday, May 19, 2022

< + > FDA Turns Down Fluvoxamine Emergency Use Authorization Request

The Food and Drug Administration denied an emergency use authorization for fluvoxamine as a SARS-CoV-2 antiviral.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Health Recovery Solutions Acquires Rimidi | Messagepoint Acquires Sefas

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare ...